Lorenzi et al. demonstrated L-ASP inhibited growth of some epithelial ovarian cancer cell lines and correlated growth inhibition with–omics findings implicating low expression of the enzyme asparagine synthetase (ASNS), that breaks down L-ASP, in a fraction of ovarian cancer patients [12, 13]. This evidence concerns the gene ASNS and ovarian carcinoma.